Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: First in Human Study to Assess Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus [NA]

View source ↗

Summary

A first-in-human study is evaluating the safety and efficacy of an implantable nitinol device for treating keratoconus. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • implantable nitinol device for keratoconus

Snippet

Sponsor: Recornea Srl | Conditions: Keratoconus | NA | Status: RECRUITING